Cardiovascular Systems Return on Investment 2006-2019 | CSII

Current and historical return on investment (ROI) values for Cardiovascular Systems (CSII) over the last 10 years.
Cardiovascular Systems ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-09-30 $-0.00B $0.16B -2.44%
2019-06-30 $-0.00B $0.17B -0.62%
2019-03-31 $0.00B $0.16B 1.26%
2018-12-31 $0.00B $0.16B 0.65%
2018-09-30 $0.00B $0.16B 0.66%
2018-06-30 $0.00B $0.16B 1.36%
2018-03-31 $-0.00B $0.15B -0.70%
2017-12-31 $-0.00B $0.15B -2.15%
2017-09-30 $-0.00B $0.14B -1.93%
2017-06-30 $-0.00B $0.14B -2.93%
2017-03-31 $-0.01B $0.13B -23.88%
2016-12-31 $-0.03B inf%
2016-09-30 $-0.05B inf%
2016-06-30 $-0.06B inf%
2016-03-31 $-0.06B inf%
2015-12-31 $-0.05B inf%
2015-09-30 $-0.04B inf%
2015-06-30 $-0.03B inf%
2015-03-31 $-0.03B inf%
2014-12-31 $-0.03B inf%
2014-09-30 $-0.04B inf%
2014-06-30 $-0.03B -191.55%
2014-03-31 $-0.03B -85.52%
2013-12-31 $-0.03B -46.43%
2013-09-30 $-0.02B $0.07B -36.36%
2013-06-30 $-0.02B $0.07B -37.61%
2013-03-31 $-0.02B $0.08B -37.07%
2012-12-31 $-0.02B $0.04B -45.28%
2012-09-30 $-0.02B $0.04B -43.59%
2012-06-30 $-0.02B $0.05B -40.82%
2012-03-31 $-0.01B $0.03B -36.36%
2011-12-31 $-0.01B $0.04B -32.00%
2011-09-30 $-0.01B $0.03B -27.83%
2011-06-30 $-0.01B $0.03B -43.37%
2011-03-31 $-0.01B $0.03B -60.00%
2010-12-31 $-0.02B $0.03B -118.52%
2010-09-30 $-0.02B -311.11%
2010-06-30 $-0.02B $0.03B -340.74%
2010-03-31 $-0.03B -285.71%
2009-12-31 $-0.03B -285.71%
2009-06-30 $-0.03B $0.04B -297.14%
2009-03-31 $-0.04B inf%
2008-06-30 $-0.04B inf%
2008-03-31 $0.03B inf%
2007-06-30 $0.04B inf%
2007-03-31 $-0.03B inf%
2006-06-30 $-0.02B inf%
2006-03-31 $-0.02B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.522B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $149.261B 20.95
Abbott Laboratories (ABT) United States $149.010B 27.18
Stryker (SYK) United States $76.714B 25.79
Boston Scientific (BSX) United States $58.945B 27.82
Baxter (BAX) United States $41.416B 25.11
EssilorLuxottica Societe Anonyme (ESLOY) France $33.904B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.822B 18.71
Terumo (TRUMY) Japan $26.925B 33.60
Coloplast (CLPBY) Denmark $25.499B 40.71
Lonza Group Ag (LZAGY) Switzerland $25.289B 0.00
ResMed (RMD) United States $21.249B 39.20
Smith & Nephew SNATS (SNN) United Kingdom $19.012B 0.00
Sunny Optical Technology (SNPTF) China $17.210B 0.00
Insulet (PODD) United States $11.282B 536.73
Bio-Rad Laboratories (BIO) United States $10.725B 51.48
Hill-Rom Holdings (HRC) United States $6.983B 20.59
Perrigo (PRGO) Ireland $6.665B 12.43
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.037B 40.79
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
Canopy Growth (CGC) Canada $4.955B 0.00
NuVasive (NUVA) United States $3.778B 29.75
ICU Medical (ICUI) United States $3.688B 24.04
Neogen (NEOG) United States $3.350B 56.05
GW Pharmaceuticals (GWPH) United Kingdom $3.165B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.147B 0.00
Quidel (QDEL) United States $2.687B 25.50
Aurora Cannabis (ACB) Canada $2.346B 0.00
National Vision Holdings (EYE) United States $2.162B 48.80
Agios Pharmaceuticals (AGIO) United States $2.128B 0.00
InMode (INMD) Israel $1.670B 0.00
AtriCure (ATRC) United States $1.126B 0.00
VAREX IMAGING (VREX) United States $1.125B 22.54
Aphria (APHA) $0.961B 0.00
Phibro Animal Health (PAHC) United States $0.923B 17.28
NanoString Technologies (NSTG) United States $0.838B 0.00
Lantheus Holdings (LNTH) United States $0.825B 20.62
TG Therapeutics (TGTX) United States $0.790B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.777B 29.75
LeMaitre Vascular (LMAT) United States $0.685B 38.49
Omeros (OMER) United States $0.661B 0.00
PetIQ (PETQ) United States $0.655B 15.99
Quanterix (QTRX) United States $0.628B 0.00
Cerus (CERS) United States $0.613B 0.00
Surmodics (SRDX) United States $0.533B 55.68
OraSure Technologies (OSUR) United States $0.484B 29.04
Owens & Minor (OMI) United States $0.419B 15.51
MacroGenics (MGNX) United States $0.413B 0.00
HEXO (HEXO) $0.409B 0.00
Utah Medical Products (UTMD) United States $0.378B 27.36
Meridian Bioscience (VIVO) United States $0.374B 12.88
Organigram Holdings (OGI) Canada $0.322B 0.00
BioLife Solutions (BLFS) United States $0.302B 123.08
Zynex (ZYXI) United States $0.299B 33.81
Vapotherm (VAPO) United States $0.244B 0.00
United Health Products (UEEC) United States $0.240B 0.00
Viemed Healthcare (VMD) United States $0.239B 0.00
Bovie Medical (APYX) United States $0.239B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.233B 0.00
Repro-Med Systems (KRMD) United States $0.164B 0.00
InfuSystems Holdings (INFU) United States $0.146B 734.00
Cytosorbents (CTSO) United States $0.133B 0.00
Rockwell Medical (RMTI) United States $0.131B 0.00
Fonar (FONR) United States $0.130B 9.18
Liberty Health Sciences (LHSIF) Canada $0.124B 0.00
Female Health (VERU) United States $0.123B 0.00
Chimerix (CMRX) United States $0.122B 0.00
United-Guardian (UG) United States $0.088B 22.24
Chembio Diagnostics (CEMI) United States $0.079B 0.00
Nephros (NEPH) United States $0.064B 0.00
MTech Acquisition (KERN) United States $0.057B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.046B 0.00
Surface Oncology (SURF) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00